News

Wound healing after skin cancer surgery and laser treatments

Wound healing after skin cancer surgery and laser treatments

May is skin cancer awareness month. Worldwide every year between 2 to 3 million people are diagnosed with non-melanoma skin cancer and 132’000 with melanoma. One in every three cancers diagnosed is a skin cancer which makes it the most common type of cancer.¹

 

 

In the US the likelihood to develop skin cancer is noticeably high: one in every five Americans will develop skin cancer in their lifetime according to the Skin Cancer Foundation Statistics.² Dr. Anna Pare and Dr. Kathleen Viscusi talk about healing scars on “Atlanta & Company” for skin cancer awareness month. In their dermatology clinics “Dermatology Consultants” in Georgia (USA) specialize in MOHS surgery, a specific type of surgery to remove skin cancers effectively while sparing as much healthy tissue as possible. They rely on the primary wound dressing Stratamed to improve the healing time and scar outcome. Stratamed “wound healer” works wonderfully after any type of surgical intervention as described by Dr. Pare.

Additional procedures performed in their clinic are different rejuvenation treatments. They share their experience with a primary wound dressing specifically after laser rejuvenation procedures, chemical peels and micro needling. Stratacel, an advanced wound dressing for the use after fractional procedures, reduces the recovery time of patients and helps improve the treatment outcome.  See the whole interview about Dr. Pare’s and Dr. Viscusi’s experience with Stratamed and Stratacel – breakthrough products in post procedure care – here.   

 

 

 

 

 
  • Text Hover
                                



  1. Breakthroughs in post-procedure care with Dermatology Consultants. https://www.11alive.com/video/entertainment/television/programs/atlanta-and-company/breakthroughs-in-post-procedure-care-with-dermatology-consultants/85-8101604 Published April 19, 2018. Accessed April 26, 2018.

  2. Stern RS. Prevalence of a history of skin cancer in 2007: results of an incidence-based model. Arch Dermatol. 2010 Mar;146(3):279-82.